More than 50 conservative leaders sign letter against Trump drug pricing policy codification [View all]

Source: The Hill

02/12/26 7:08 AM ET


A coalition of more than 50 leaders of conservative and free-market organizations signed a letter to members of Congress on Thursday, opposing codifying President Trump’s “most favored nation” (MFN) drug pricing policy model into law. The letter, which argues an MFN pricing law would “import socialist price controls and values into our country,” highlights the growing tension between Trump and a portion of the conservative movement.

“In addition to doing nothing to address foreign freeloading, MFN would reduce access to new cures and reduce U.S. global competitiveness, ceding ground to China,” the leaders wrote.

“While supporters of this proposal correctly identify the unique problems facing the American health care system — namely, wealthy countries paying artificially lower prices for prescription drugs than the U.S. and the fact that this depresses innovation and inflates our costs — MFN would not solve these problems,” the letter continues. “In fact, it would exacerbate them.”

Signatories of the letter include Grover Norquist, president of Americans for Tax Reform; Stephen Moore, co-founder of Unleash Prosperity Now and a former economic adviser to Trump; Tim Chapman, president of Advancing American Freedom; Phil Kerpen, president of American Commitment; Ryan Ellis, president of Center for a Free Economy; Alfredo Ortiz, CEO of the Job Creators Network; Morton Blackwell, a Virginia Republican National Committee member; Emily Stack, executive director of Moms for America Action; Pete Sepp, president of National Taxpayers Union; and David Williams, president of Taxpayers Protection Alliance.

Read more: https://thehill.com/policy/healthcare/5734862-conservative-leaders-oppose-trump-drug-pricing-policy/